# Xtrackers MSCI USA Health Care UCITS ETF (XSHC)

**Page:** https://fundology.uk/fund/xshc · ISIN IE00BCHWNW54

## At a glance

> Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.

As of 13/11/2026, XSHC (Xtrackers MSCI USA Health Care UCITS ETF, ISIN IE00BCHWNW54) closed at £56.67 on the London Stock Exchange. Its ongoing charge is 0.12% a year (about £12 on £10,000). Over the five years to 13/11/2026 its total return was +48.3%, or +15.7% after UK CPIH inflation.

## Summary

Xtrackers MSCI USA Health Care UCITS ETF is an exchange-traded fund (ETF) from Xtrackers, launched in 2017. It tracks the MSCI USA / Health Care -SEC. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is paid out to holders as cash, usually a few times a year.

Latest close: **£56.67** (13/11/2026).

## Key facts

| Fact | Value |
|---|---|
| Ticker (LSE) | XSHC |
| ISIN | IE00BCHWNW54 |
| Also listed as | XUHC (London Stock Exchange, US dollars) |
| Category | Healthcare |
| Type | ETF |
| Provider | Xtrackers |
| Tracks | MSCI USA / Health Care -SEC |
| Income | Distributing |
| Ongoing charge | 0.12% a year (£12 per £10,000) |
| Fund size | £1.2bn |
| Launched | 2017 |
| Domicile | Ireland |
| UK reporting fund status | Yes — on HMRC’s list of reporting funds (list of 02/11/2026); reporting fund since 12/09/2017 |

## Past returns (periods to 13/11/2026)

After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after UK CPIH inflation.

| Window | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 1 year | +23.05% | +18.69% | income reinvested |
| 3 years | +41.34% | +27.70% | income reinvested |
| 5 years | +48.26% | +15.72% | income reinvested |

Returns: as reported (delayed data). Inflation: UK CPIH, latest month published.

## Calendar-year returns

Calendar-year returns of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included): 2022 +6.4%, 2023 −4.8%, 2024 +4.5%, 2025 +3.0%; 2026 to 13/11/2026 +21.5%. Returns of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included) over the 12 months to 30/09/2026: +17.6%; to 30/09/2025: −5.6%; to 30/09/2024: +8.5%; to 30/09/2023: −3.9%; to 30/09/2022: +16.5%.

| Year | Return | After CPIH inflation | Measured as |
|---|---|---|---|
| 2022 | +6.4% | -2.6% | Price |
| 2023 | -4.8% | -8.6% | Price |
| 2024 | +4.5% | +0.9% | Price |
| 2025 | +3.0% | -0.6% | Price |
| 2026 to 13/11/2026 | +21.5% | +17.7% | Price |

## Risk metrics

| Window | Volatility | Max drawdown |
|---|---|---|
| 1 year | 17.46% | -12.10% |
| 3 years | 14.64% | -19.35% |
| 5 years | 14.26% | -19.35% |

## Largest fall

Volatility of Xtrackers MSCI USA Health Care UCITS ETF in pounds, annualised from weekly returns to 13/11/2026: 17.5% over 1 year, 14.6% over 3 years, 14.3% over 5 years. Largest fall in the price of Xtrackers MSCI USA Health Care UCITS ETF since November 2021, in pounds: −19.3% from 31/01/2025 to 23/05/2025. The lowest 12-month return of Xtrackers MSCI USA Health Care UCITS ETF in pounds (price only, income paid out not included) since January 2021 was −17.2% (12 months to 08/08/2025); the highest was +27.5% (12 months to 08/04/2022). On 13/11/2026 the price of Xtrackers MSCI USA Health Care UCITS ETF was at its highest weekly close since November 2021, in pounds.

## Charges compared with similar funds

Ongoing charge of Xtrackers MSCI USA Health Care UCITS ETF 0.12% a year. Compared on 14/11/2026, 28 of the 28 other healthcare funds charge more, 0 the same and 0 less (share classes counted once).

## Charges & eligibility

- Ongoing charges figure (OCF): **0.12%** per year
- Stocks and shares ISA eligible: usually (check with your platform)
- SIPP eligible: usually (check with your provider)
- ISA and SIPP mean the kind of product usually qualifies under HMRC rules. We do not check each platform’s list — each provider decides which funds it offers. Crypto ETNs have not qualified for a stocks and shares ISA since 06/04/2026, and overseas funds that are not UK-recognised UCITS, such as Swiss ETFs, do not usually qualify.

## What it holds

As of 15/11/2026, XSHC holds 61 positions, according to its published holdings. The largest is Eli Lilly at 16.75% of the fund; the ten largest make up 60.8%.

### Top holdings

Largest positions (as of 15/11/2026), as a percentage of the whole fund:

| # | Holding | Ticker | Weight |
|---|---|---|---|
| 1 | Eli Lilly | [LLY](https://fundology.uk/stock/LLY) | 16.75% |
| 2 | Johnson & Johnson | [JNJ](https://fundology.uk/stock/JNJ) | 10.01% |
| 3 | AbbVie | [ABBV](https://fundology.uk/stock/ABBV) | 7.63% |
| 4 | UnitedHealth Group | [UNH](https://fundology.uk/stock/UNH) | 5.40% |
| 5 | Merck | [MRK](https://fundology.uk/stock/MRK) | 5.32% |
| 6 | Thermo Fisher Scientific | [TMO](https://fundology.uk/stock/TMO) | 3.81% |
| 7 | Amgen | [AMGN](https://fundology.uk/stock/AMGN) | 3.70% |
| 8 | Gilead Sciences | [GILD](https://fundology.uk/stock/GILD) | 3.06% |
| 9 | Abbott Laboratories | [ABT](https://fundology.uk/stock/ABT) | 2.74% |
| 10 | Pfizer | [PFE](https://fundology.uk/stock/PFE) | 2.41% |

## Where it invests

Shares of the whole fund. Bonds, cash and positions without a classification are shown as they come, not guessed.

### By type of asset

Added up from the fund’s published holdings, as of 15/11/2026.

| Type of asset | Weight |
|---|---|
| Equity | 99.9% |
| Cash and money market | 0.1% |

The 59 holdings on record (of 61 reported): https://fundology.uk/fund/xshc/holdings

## Questions people ask

**What is the ongoing charge of XSHC?**

The ongoing charge of XSHC is 0.12% a year — about £12 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Xtrackers MSCI USA Health Care UCITS ETF 0.12% a year. Compared on 14/11/2026, 28 of the 28 other healthcare funds charge more, 0 the same and 0 less (share classes counted once).

**What does XSHC track?**

XSHC tracks the MSCI USA / Health Care -SEC.

**Is XSHC accumulating or distributing?**

XSHC is distributing: income is paid out to holders as cash, usually a few times a year. It pays out semi-annual.

**What is the ISIN of XSHC?**

The ISIN of XSHC is IE00BCHWNW54. An ISIN identifies one exact share class of a fund; XSHC is its ticker on the London Stock Exchange. The same share class is also listed as XUHC (London Stock Exchange, US dollars).

**What does XSHC hold?**

As of 15/11/2026, XSHC holds 61 positions, according to its published holdings. The largest is Eli Lilly at 16.75% of the fund; the ten largest make up 60.8%. Its ten largest holdings are Eli Lilly (16.75%), Johnson & Johnson (10.01%), AbbVie (7.63%), UnitedHealth Group (5.40%), Merck (5.32%), Thermo Fisher Scientific (3.81%), Amgen (3.70%), Gilead Sciences (3.06%), Abbott Laboratories (2.74%) and Pfizer (2.41%).

**What were XSHC’s returns in each of the last five years?**

Calendar-year returns of XSHC in pounds (price only, income paid out not included): 2022 +6.4%, 2023 −4.8%, 2024 +4.5%, 2025 +3.0%; 2026 to 13/11/2026 +21.5%. Past performance is not a guide to future returns.

**How has XSHC done after inflation?**

Over the five years to 13/11/2026 XSHC’s total return was +48.3%, or +15.7% after UK CPIH inflation. Past performance is not a guide to future returns.

## Fund documents

- [Fund page at Xtrackers (DWS)](https://etf.dws.com/en-gb/IE00BCHWNW54-msci-usa-health-care-ucits-etf-1d/)
- Links checked 12/10/2026.

---

We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments.

Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.